1,130 results on '"Raab, M"'
Search Results
2. Technical, economic and ecological assessment of European sustainable aviation fuels (SAF) production
3. Real-world analysis of teclistamab in 123 RRMM patients from Germany
4. Safe liquid scintillators for large scale detectors
5. Spontaneous grip force fluctuations mirror semantic numerical magnitude processing: Larger numbers elicit larger forces
6. Coexisting multi-states in catalytic hydrogen oxidation on rhodium
7. BRAF-Inhibitoren in der Therapie des multiplen Myeloms
8. CO Oxidation on Stepped Rh Surfaces: μm-Scale Versus Nanoscale
9. The ALMANACH Project: Preliminary results and potentiality from Afghanistan
10. Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow
11. Embodied Perspectives on Behavioral Cognitive Enhancement
12. Primärtherapie beim Multiplen Myelom
13. How to not induce SNAs: The insufficiency of directional force
14. A dissociable functional relevance of theta- and beta-band activities during complex sensorimotor integration
15. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
16. TRACK: A new algorithm and open-source tool for the analysis of pursuit-tracking sensorimotor integration processes
17. The neurophysiology of continuous action monitoring
18. Forschungsinitiative Energiewende im Verkehr. Kurzbericht zur Roadmap für strombasierte Kraftstoffe
19. Roadmap für strombasierte Kraftstoffe. Gesamtbericht zur Begleitforschung Energiewende im Verkehr (BEniVer)
20. ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death
21. Conceptual MMV Outline: Illinois CarbonSafe Prairie Project
22. Cobimetinib alone and plus venetoclax with/without atezolizumab in patients with relapsed/refractory multiple myeloma
23. Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus
24. Homer1 (VesL-1) in the rat esophagus: focus on myenteric plexus and neuromuscular junction
25. Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma
26. Safe liquid scintillators for large scale detectors
27. A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM): INITIAL SAFETY RESULTS FOR MAGNETISMM-3
28. Micromanufactured electrodes for cortical field potential recording: in vivo study
29. E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271
30. Techno‐Economic and Environmental Assessment of Multiple Energy Transition Options – Methodology and Results
31. Micro- and macronutrient intake in myeloma patients correlates with clinical parameters: potential implications for supportive care
32. PB1983: TRIAL-IN-PROGRESS: PHASE II STUDY OF PHE885, A B-CELL MATURATION ANTIGEN-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
33. P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
34. P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL
35. P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA
36. PB1976: CRISPR-CAS9 KNOCKOUT SCREEN IDENTIFIES RNA MODIFICATION ENZYMES ESSENTIAL FOR CELL SURVIVAL IN MULTIPLE MYELOMA
37. P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DANTE TRIAL
38. P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3
39. Supermolecular Structure and Mechanical Behaviour of Isotactic Polypropylene
40. 147 Development of an Ultrasound Algorithm Enabled Handheld Automated Needle Decompression Device (ANeeD) for Pneumothorax Decompression in a Live Swine Model
41. Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma
42. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
43. Erratum zu: Primärtherapie beim Multiplen Myelom
44. Die seltene thorakale Manifestation eines extramedullären Myeloms
45. P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY
46. Übermolekulare Struktur und mechanische Eigenschaften von isotaktischem Polypropylen
47. Gleichstrom zur Behandlung maligner Weichteiltumoren im Tierexperiment
48. Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure
49. Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma
50. Localization of receptors for calcitonin-gene-related peptide to intraganglionic laminar endings of the mouse esophagus: peripheral interaction between vagal and spinal afferents?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.